Diabetes, Vol 47, Issue 9 1444-1450, Copyright © 1998 by American Diabetes Association
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes
CG Fanelli, CS Dence, J Markham, TO Videen, DS Paramore, PE Cryer and WJ Powers
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
To test the hypothesis that blood-to-brain glucose transport is reduced in
poorly controlled type 1 diabetes, we studied seven patients with a mean
(+/- SD) HbA1c level of 10.1 +/- 1.2% and nine nondiabetic subjects during
hyperinsulinemic, mildly hypoglycemic (approximately 3.6 mmol/l,
approximately 65 mg/dl) glucose clamps. Blood-to-brain glucose transport
and cerebral glucose metabolism were calculated from rate constants derived
from blood and brain time-activity curves--the latter determined by
positron emission tomography (PET)--after intravenous injection of
[1-(11)C]glucose using a model that includes a fourth rate constant to
account for regional egress of 11C metabolites. Cerebral blood flow and
cerebral blood volume were determined with intravenous H2(15)O and inhaled
C(15)O, respectively, also by PET. At plateau plasma glucose concentrations
of 3.6 +/- 0.0 and 3.7 +/- 0.1 mmol/l, rates of blood-to-brain glucose
transport were similar in the two groups (23.7 +/- 2.2 and 21.6 +/- 2.9
micromol x 100 g(-1) x min(-1), P = 0.569, in the control subjects and the
patients, respectively). There were also no differences in the rates of
cerebral glucose metabolism (16.8 +/- 0.8 and 16.3 +/- 1.2 micromol x 100
g(-1) x min(-1), P = 0.693, respectively). Plasma epinephrine (1,380 +/-
340 vs. 450 +/- 170 pmol/l, P = 0.0440) and glucagon (26 +/- 5 vs. 12 +/- 1
pmol/l, P = 0.0300) responses to mild hypoglycemia were reduced in the
patients with type 1 diabetes. We conclude that neither blood-to-brain
glucose transport nor cerebral glucose metabolism is measurably reduced in
people with poorly controlled type 1 diabetes.